Schisandrin B identified by CMC ameliorates PGN-induced immune colitis and DSS-triggered ulcerative colitis by targeting TLR2 and blocking TLR2 heterodimerization

Energy and Built Environment · Elsevier

Аннотация

Publication date: Available online 30 September 2026 Source: Journal of Pharmaceutical Analysis Author(s): Luyun Yang, Yingchao Li, Chunyan Yin, Litao Wu, Kexin Cheng, Jiafu Liang, Xiaona Cheng, Quan Zhang, Yakun Huang, Haoyun Bai, Wenlong Wang, Kaikai Lu, Rong Zhao, Zizhen Guo, Mingzhen Zhang, Shengli Han, Dongmin Li

Читать у издателя →

Похожие статьи